Global Intravenous Iron Drugs Market 2017-2021
- Published: Apr 2017
- Pages: 70
- SKU: IRTNTR12441
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This market research study identifies Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, and Pharmacosmos as the leading players in the global intravenous (IV) iron drugs market. A comprehensive analysis of this market is also presented by the product type (ferric carboxy maltose, sucrose, dextran, and others) and by geography (the Americas, APAC, and EMEA).
Overview of the global intravenous iron drugs market
According to Technavio’s market research analysts, the global intravenous iron drugs market will grow at a steady rate and post a CAGR of more than 10% during the forecast period. The growing demand for non-dextran IV iron drugs will drive the growth prospects for the global intravenous iron drugs market until the end of 2021. The market is witnessing a high degree of shift from conventional dextran intravenous iron drugs to non-dextran intravenous iron drugs due to the growing demand for non-dextran intravenous iron drugs, which in turn, will fuel the market’s growth in the coming years. One of the major factors responsible for the growing demand for non-dextran intravenous iron drugs is its ability to deliver larger doses of iron infusion in a short time. Furthermore, these drugs also have the ability to address challenges such as intolerance or an unsatisfactory response, safety concerns, and dosing and compliance issues associated with conventional iron therapies, which will again, fuel their demand in the coming years.
The increase in favorable guidelines from health care organizations will drive the growth prospects for the global intravenous iron drugs market for the next four years. For instance, the European Society of Cardiology posted guidelines that strongly recommend the use of Ferinject for the treatment of iron deficiency in patients with systolic heart failure, in turn, driving the adoption rate of intravenous iron drugs.
Competitive landscape and key vendors
The global intravenous iron drugs market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly competing against each other based on factors such as aggressive pricing, novel therapeutics, and technological advancements. The development of non-dextran therapies, expansion of applications, awareness programs, cost-effective drugs, and effective marketing strategies are some of the strategic success factors of the major players in the market. Furthermore, these vendors are also increasingly focusing on the development of novel drugs such as ferric carboxy maltose.
Key vendors in this market are -
- Allergan
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Galenica
- Pharmacosmos
Other prominent vendors in the market include Nippon Shinyaku, NOXXON Pharma, Rockwell Medical, Sanofi, and Wanbang Biopharmaceutical.
Segmentation by product type and analysis of the intravenous iron drugs market
- Ferric carboxy maltose
- Sucrose
- Dextran
The ferric carboxy maltose segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market segment's growth is the increasing number of benefits of ferric carboxy maltose over other conventional drugs, their safety and efficacy profiles, and the ability to rapidly replace iron stores in the body. Moreover, these drugs can also be prescribed in higher doses in comparison to conventional drugs. For instance, the dosage range of ferric carboxy maltose is 500-1000 mg/infusion.
Segmentation by geography and analysis of the intravenous iron drugs market
- Americas
- APAC
- EMEA
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. One of the major factors responsible for the market's growth in the region is the expansion strategies adopted by a large number of vendors that will boost the consumption and product reach across the Americas. Furthermore, the increasing incidence of iron deficiency anemia will further fuel the consumption of intravenous iron drugs, which, in turn, will propel the rate of revenue generation in the market.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global intravenous iron drugs market?
- What are the key market trends impacting the growth of the global intravenous iron drugs market?
- What are the challenges to market growth?
- Who are the key vendors in the global intravenous iron drugs market?
- What are the market opportunities and threats faced by the vendors in the global intravenous iron drugs market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global intravenous iron drugs market?
Technavio also offers customization on reports based on specific client requirement.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- Key market highlights
PART 05: An overview of iron deficiency
PART 06: Pipeline landscape
PART 07: Market landscape
- Market overview
- Five forces analysis
PART 08: Market segmentation by product type
- Ferric carboxymaltose
- Sucrose
- Dextran
- Others
PART 09: Geographical segmentation
- Intravenous iron drugs market in Americas
- Intravenous iron drugs market in EMEA
- Intravenous iron drugs market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
- Market drivers
- Impact of drivers on key customer segments
- Market challenges
- Impact of challenges on key customer segments
PART 12: Market trends
- Increase in favorable guidelines from healthcare organizations
- Increasing strategies of vendors to expand reach of intravenous iron drugs
- Growing focus on emerging economies
PART 13: Vendor landscape
- Competitive scenario
PART 14: Key vendor analysis
- Allergan
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Galenica
- Pharmacosmos
- Other prominent vendors
PART 15: Appendix
- List of abbreviation
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
